QQ客服 官方微博 反馈留言

	Variation of Programmed Death Ligand 1 Expression After Platinum-based Neoadjuvant Chemotherapy in Lung Cancer
	Guo, Lei; Song, Peng; Xue, Xuemin; Guo, Changyuan; Han, Liankui; Fang, Qing; Ying, Jianming; Gao, Shugeng; Li, Wenbin
	2019
卷号	42期号:6页码:215-220
关键词	programmed death ligand 1 (PD-L1) chemotherapy lung cancer survival
ISSN号	1524-9557
DOI	10.1097/CJI.0000000000000275
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6337488
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Guo, Lei,Song, Peng,Xue, Xuemin,et al. Variation of Programmed Death Ligand 1 Expression After Platinum-based Neoadjuvant Chemotherapy in Lung Cancer[J],2019,42(6):215-220.
APA	Guo, Lei.,Song, Peng.,Xue, Xuemin.,Guo, Changyuan.,Han, Liankui.,...&Li, Wenbin.(2019).Variation of Programmed Death Ligand 1 Expression After Platinum-based Neoadjuvant Chemotherapy in Lung Cancer.,42(6),215-220.
MLA	Guo, Lei,et al."Variation of Programmed Death Ligand 1 Expression After Platinum-based Neoadjuvant Chemotherapy in Lung Cancer".42.6(2019):215-220.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。